Cargando…
Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin
Cardiosiderosis is a leading cause of mortality in transfusion-dependent thalassemias. Plasma non-transferrin-bound iron and its redox-active component, labile plasma iron, are key sources of iron loading in cardiosiderosis. Risk factors were identified in 73 patients with or without cardiosiderosis...
Autores principales: | Garbowski, Maciej W., Evans, Patricia, Vlachodimitropoulou, Evangelia, Hider, Robert, Porter, John B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622848/ https://www.ncbi.nlm.nih.gov/pubmed/28642302 http://dx.doi.org/10.3324/haematol.2017.170605 |
Ejemplares similares
-
Renal Hemosiderosis among Iranian Transfusion Dependent β-Thalassemia Major
Patients
por: Hashemieh, Mozhgan, et al.
Publicado: (2017) -
Erythropoiesis and Iron Homeostasis in Non-Transfusion-Dependent Thalassemia Patients with Extramedullary Hematopoiesis
por: Huang, Yumei, et al.
Publicado: (2019) -
Intravenous iron preparations transiently generate non-transferrin-bound iron from two proposed pathways
por: Garbowski, Maciej W., et al.
Publicado: (2020) -
Imbalance of erythropoiesis and iron metabolism in patients with thalassemia
por: Huang, Yumei, et al.
Publicado: (2019) -
P1465: SAFETY AND EFFICACY OF APOTRANSFERRIN INFUSION IN PATIENTS WITH BETA-THALASSEMIA INTERMEDIA, THE AIM STUDY
por: Konté, Kadère, et al.
Publicado: (2023)